Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Allosteric control of cyclic di-GMP signaling.

Christen B, Christen M, Paul R, Schmid F, Folcher M, Jenoe P, Meuwly M, Jenal U.

J Biol Chem. 2006 Oct 20;281(42):32015-24. Epub 2006 Aug 21.

2.

Identification and characterization of a cyclic di-GMP-specific phosphodiesterase and its allosteric control by GTP.

Christen M, Christen B, Folcher M, Schauerte A, Jenal U.

J Biol Chem. 2005 Sep 2;280(35):30829-37. Epub 2005 Jul 1.

3.

The structure and inhibition of a GGDEF diguanylate cyclase complexed with (c-di-GMP)(2) at the active site.

Yang CY, Chin KH, Chuah ML, Liang ZX, Wang AH, Chou SH.

Acta Crystallogr D Biol Crystallogr. 2011 Dec;67(Pt 12):997-1008. doi: 10.1107/S090744491104039X. Epub 2011 Nov 18.

PMID:
22120736
4.

An oxygen-sensing diguanylate cyclase and phosphodiesterase couple for c-di-GMP control.

Tuckerman JR, Gonzalez G, Sousa EH, Wan X, Saito JA, Alam M, Gilles-Gonzalez MA.

Biochemistry. 2009 Oct 20;48(41):9764-74. doi: 10.1021/bi901409g.

PMID:
19764732
5.

Monitoring of diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors.

Antoniani D, Bocci P, Maciag A, Raffaelli N, Landini P.

Appl Microbiol Biotechnol. 2010 Jan;85(4):1095-104. doi: 10.1007/s00253-009-2199-x. Epub 2009 Aug 26.

PMID:
19707751
6.

Conservative change to the phosphate moiety of cyclic diguanylic monophosphate remarkably affects its polymorphism and ability to bind DGC, PDE, and PilZ proteins.

Wang J, Zhou J, Donaldson GP, Nakayama S, Yan L, Lam YF, Lee VT, Sintim HO.

J Am Chem Soc. 2011 Jun 22;133(24):9320-30. doi: 10.1021/ja1112029. Epub 2011 May 25.

PMID:
21612220
7.

Cyclic-di-GMP-mediated signalling within the sigma network of Escherichia coli.

Weber H, Pesavento C, Possling A, Tischendorf G, Hengge R.

Mol Microbiol. 2006 Nov;62(4):1014-34. Epub 2006 Sep 29.

8.

GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility.

Simm R, Morr M, Kader A, Nimtz M, Römling U.

Mol Microbiol. 2004 Aug;53(4):1123-34.

9.

Beyond antibiotic resistance: integrating conjugative elements of the SXT/R391 family that encode novel diguanylate cyclases participate to c-di-GMP signalling in Vibrio cholerae.

Bordeleau E, Brouillette E, Robichaud N, Burrus V.

Environ Microbiol. 2010 Feb;12(2):510-23. doi: 10.1111/j.1462-2920.2009.02094.x. Epub 2009 Nov 3.

PMID:
19888998
10.

Crystal structure of a catalytically active GG(D/E)EF diguanylate cyclase domain from Marinobacter aquaeolei with bound c-di-GMP product.

Vorobiev SM, Neely H, Yu B, Seetharaman J, Xiao R, Acton TB, Montelione GT, Hunt JF.

J Struct Funct Genomics. 2012 Sep;13(3):177-83. doi: 10.1007/s10969-012-9136-4. Epub 2012 Jul 29.

11.
12.

[Activity of cyclic diguanylate (c-di-GMP) in bacteria and the study of its derivatives].

Na LX, Yang ZJ.

Yao Xue Xue Bao. 2012 Mar;47(3):307-12. Review. Chinese.

PMID:
22645753
13.

Potent suppression of c-di-GMP synthesis via I-site allosteric inhibition of diguanylate cyclases with 2'-F-c-di-GMP.

Zhou J, Watt S, Wang J, Nakayama S, Sayre DA, Lam YF, Lee VT, Sintim HO.

Bioorg Med Chem. 2013 Jul 15;21(14):4396-404. doi: 10.1016/j.bmc.2013.04.050. Epub 2013 Apr 29.

PMID:
23685177
14.

Structure of BeF3- -modified response regulator PleD: implications for diguanylate cyclase activation, catalysis, and feedback inhibition.

Wassmann P, Chan C, Paul R, Beck A, Heerklotz H, Jenal U, Schirmer T.

Structure. 2007 Aug;15(8):915-27. Erratum in: Structure. 2007 Sep;15(9):1155.

15.

Genome-Based Comparison of Cyclic Di-GMP Signaling in Pathogenic and Commensal Escherichia coli Strains.

Povolotsky TL, Hengge R.

J Bacteriol. 2015 Aug 24;198(1):111-26. doi: 10.1128/JB.00520-15.

16.

A flavin cofactor-binding PAS domain regulates c-di-GMP synthesis in AxDGC2 from Acetobacter xylinum.

Qi Y, Rao F, Luo Z, Liang ZX.

Biochemistry. 2009 Nov 3;48(43):10275-85. doi: 10.1021/bi901121w.

PMID:
19785462
17.

Nitric oxide regulation of cyclic di-GMP synthesis and hydrolysis in Shewanella woodyi.

Liu N, Xu Y, Hossain S, Huang N, Coursolle D, Gralnick JA, Boon EM.

Biochemistry. 2012 Mar 13;51(10):2087-99. doi: 10.1021/bi201753f. Epub 2012 Mar 5.

PMID:
22360279
18.

The Inhibitory Site of a Diguanylate Cyclase Is a Necessary Element for Interaction and Signaling with an Effector Protein.

Dahlstrom KM, Giglio KM, Sondermann H, O'Toole GA.

J Bacteriol. 2016 May 13;198(11):1595-603. doi: 10.1128/JB.00090-16. Print 2016 Jun 1.

19.

Interaction of the diguanylate cyclase YdeH of Escherichia coli with 2',(3')-substituted purine and pyrimidine nucleotides.

Spangler C, Kaever V, Seifert R.

J Pharmacol Exp Ther. 2011 Jan;336(1):234-41. doi: 10.1124/jpet.110.170993. Epub 2010 Oct 14.

20.

Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulence.

Kulasakara H, Lee V, Brencic A, Liberati N, Urbach J, Miyata S, Lee DG, Neely AN, Hyodo M, Hayakawa Y, Ausubel FM, Lory S.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2839-44. Epub 2006 Feb 13.

Supplemental Content

Support Center